Viridium Pacific Group (VIR) Stock Price, News & Analysis

Company Overview

Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.

Key Stats

• Today's Range: C$0.37 to C$0.41
• 50-Day Range: C$0.38 to C$0.38
• 52-Week Range: C$0.36 to C$1.15
• Volume: 26,500 shs
• Average Volume: 92,632 shs
• Market Capitalization: C$37.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VIR Stock Analysis - Frequently Asked Questions

How have VIR shares performed this year?

Viridium Pacific Group's stock was trading at C$0.38 on January 1st, 2025. Since then, VIR shares have increased by 0.0% and is now trading at C$0.38.

How do I buy shares of Viridium Pacific Group?

Shares of VIR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Viridium Pacific Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Viridium Pacific Group investors own include Baytex Energy (BTE), Allena Pharmaceuticals (ALNA), Abacus Health Products (ABAHF), Aurora Cannabis (ACBFF), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS) and Ardelyx (ARDX).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: CVE:VIR
• CIK: N/A
• Web: www.viridiumpacific.com
• Phone: 604-837-8688
• Fax: N/A
• Employees: 580
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 10.28
• Quick Ratio: 9.91

Sales & Book Value

• Annual Sales: C$1.09 million
• Price / Sales: 34.46
• Cash Flow: C$0.13 per share
• Price / Cash Flow: 2.92
• Book Value: C$0.29 per share
• Price / Book: 1.30

Miscellaneous

• Outstanding Shares: 98,733,000
• Free Float: N/A
• Market Cap: C$37.52 million
• Optionable: Not Optionable
• Beta: N/A